Yeung K, Trowbridge A A
Cancer. 1977 Jan;39(1):359-65. doi: 10.1002/1097-0142(197701)39:1<359::aid-cncr2820390155>3.0.co;2-c.
Acute myelofibrosis is a rare but distinct accelerated variant of agnogenic myeloid metaplasia that is characterized by marked anemia, peripheral blood myeloblastosis and normoblastosis, a lack of teardrop poikilocytosis, and prominent myelofibrosis. There is usually no palpable hepatosplenomegaly or lymph node enlargement. The clinical course is remarkable short. We describe a 63-year-old man who presented with idiopathic acquired sideroblastic anemia and subsequently developed acute myelofibrosis. Intensive polychemotherapy with vincristine, cytosine arabinoside, and prednisone and a later trial of oxymetholone therapy were ineffective. He died 134 days after the diagnosis of acute myelofibrosis was established. The 11 previously reported cases of acute myelofibrosis are reviewed, and the relationships of acute myelofibrosis to other myeloproliferative disorders and to idiopathic acquired sideroblastic anemia are discussed.
急性骨髓纤维化是一种罕见但独特的促红细胞生成素生成性骨髓化生加速变体,其特征为显著贫血、外周血成髓细胞增多和幼红细胞增多、无泪滴状异形红细胞症,以及显著的骨髓纤维化。通常无肝脾肿大或淋巴结肿大。临床病程明显较短。我们描述了一名63岁男性,他最初表现为特发性获得性铁粒幼细胞贫血,随后发展为急性骨髓纤维化。使用长春新碱、阿糖胞苷和泼尼松进行的强化多药化疗以及后来的羟甲烯龙治疗试验均无效。在急性骨髓纤维化诊断确立134天后他死亡。回顾了之前报道的11例急性骨髓纤维化病例,并讨论了急性骨髓纤维化与其他骨髓增殖性疾病以及特发性获得性铁粒幼细胞贫血的关系。